I’d like to share with you my #1 high-conviction stock to buy before Inauguration Day… and details on the assets that could help you create wealth from these events, even as so many others watch their portfolios destroyed.

Everything you need to know is here in my emergency broadcast.

John Bilbrey Biography and Net Worth

Director of Elanco Animal Health

John Bilbrey has served as a member of the Elanco board of directors since March 2019.

John Bilbrey served as the CEO and president of The Hershey Company until 2017. He also held multiple leadership roles throughout his 14-year tenure with the company, including chief operating officer and executive vice president, president of North America, and president of International Commercial group.

Bilbrey’s past professional experience includes positions as president and CEO of Danone Waters of North America, executive vice president of sales for Mission Foods, and more than 20 years of international consumer sales and marketing experience at Proctor & Gamble. Additionally, he is the owner and operator of Commercial Cattle Operations of Bilbrey Farms and Ranch.

Bilbrey served as non-executive chairman of The Hershey Company until 2018 and an independent director of McCormick & Company, Inc. until 2015. He currently is as an independent director on the board of Colgate-Palmolive Company. Bilbrey earned a bachelor’s degree in psychology from Kansas State University.

What is John P. Bilbrey's net worth?: The estimated net worth of John P. Bilbrey is at least $3.50 million as of August 19th, 2024. Mr. Bilbrey owns 241,593 shares of Elanco Animal Health stock worth more than $3,503,099 as of November 8th. This net worth evaluation does not reflect any other assets that Mr. Bilbrey may own. Learn More about John P. Bilbrey's net worth.
How do I contact John P. Bilbrey?: The corporate mailing address for Mr. Bilbrey and other Elanco Animal Health executives is 2500 INNOVATION WAY, GREENFIELD IN, 46140. Elanco Animal Health can also be reached via phone at (877) 352-6261 and via email at [email protected]. Learn More on John P. Bilbrey's contact information.
Has John P. Bilbrey been buying or selling shares of Elanco Animal Health?: John P. Bilbrey has not been actively trading shares of Elanco Animal Health during the last ninety days. Most recently, on Friday, November 11th, John P. Bilbrey bought 7,500 shares of Elanco Animal Health stock. The stock was acquired at an average cost of $13.24 per share, with a total value of $99,300.00. Following the completion of the transaction, the director now directly owns 41,722 shares of the company's stock, valued at $552,399.28. Learn More on John P. Bilbrey's trading history.
Who are Elanco Animal Health's active insiders?: Elanco Animal Health's insider roster includes John Bilbrey (Director), Art Garcia (Director), Michael Harrington (Director), R. Hoover (Director), Rajeev Modi (Insider), Jeffrey Simmons (CEO), and Todd Young (Insider). Learn More on Elanco Animal Health's active insiders.
Are insiders buying or selling shares of Elanco Animal Health?: During the last year, Elanco Animal Health insiders bought shares 4 times. They purchased a total of 138,500 shares worth more than $1,930,475.00. The most recent insider tranaction occured on August, 22nd when Director Michael J Harrington bought 3,500 shares worth more than $51,975.00. Insiders at Elanco Animal Health own 0.6% of the company. Learn More about insider trades at Elanco Animal Health.
Information on this page was last updated on 8/22/2024.

John P. Bilbrey Insider Trading History at Elanco Animal Health

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/11/2022	Buy	7,500	$13.24	$99,300.00	41,722
5/11/2022	Buy	10,000	$22.03	$220,300.00	34,222
8/19/2020	Buy	9,580	$26.20	$250,996.00	8,016
3/6/2020	Buy	3,000	$25.15	$75,450.00	8,016
11/22/2019	Buy	3,766	$26.58	$100,100.28	2,783
5/13/2019	Buy	7,750	$32.39	$251,022.50

John P. Bilbrey Buying and Selling Activity at Elanco Animal Health

Elanco Animal Health Company Overview

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.

Today's Range

Now: $14.50

$12.87

$14.75

50 Day Range

MA: $13.95

$12.38

$15.47

2 Week Range

Now: $14.50

$10.19

$18.80

Volume

9,244,498 shs

Average Volume

4,785,154 shs

Market Capitalization

$7.17 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.41

Urgent: This election is rigged

From Porter & Company | Ad